Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

The severity of COVID-19 has resulted in a global rush to find the right antiviral treatment to conquer the pandemic and to treat patients. This requires reliable studies to support treatment. In a recently published study by Gautret et al. the authors concluded that hydroxychloroquine monotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Machiels, Julian D, Bleeker-Rovers, Chantal P, ter Heine, Rob, Rahamat-Langendoen, Janette, de Mast, Quirijn, ten Oever, Jaap, Bousema, Teun, van Crevel, Reinout, Wertheim, Heiman FL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357524/
https://www.ncbi.nlm.nih.gov/pubmed/32674929
http://dx.doi.org/10.1016/j.ijantimicag.2020.106056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357524/
https://www.ncbi.nlm.nih.gov/pubmed/32674929
http://dx.doi.org/10.1016/j.ijantimicag.2020.106056

Ejemplares similares